Partnering with a reliable EDC vendor to ensure your clinical trial data meets high standards of accuracy and integrity is essential for passing FDA scrutiny. Risk-based approaches and improved monitoring workflows can help researchers stay ahead of the curve in navigating any potential challenges posed by the FDA, reducing the risk of warnings, rejections or costly additional research.
eConsent is transforming the informed consent process, making it easier for would-be trial participants to understand what’s required of them and providing sponsors with real data on participant comprehension. It’s an important step towards a future of secure, efficient clinical research that serves everyone involved.
Effective database design is essential for successful clinical studies, as it improves data quality and accuracy and increases the speed of trial times. This can be done by ensuring the database is user-friendly, utilizing new technologies such as eSource, regularly checking data trends, focusing on SDTM while designing the database, and consulting with sites to proactively address any irregularities. Ultimately, accelerated trial times rely heavily on effective database design.
To stand out in a competitive CRO market, CROs must differentiate themselves by utilizing innovative clinical trial technology and trusted partners like Medrio. This collaboration can lead to efficient builds, reduced timelines, and seamless client experiences, ultimately setting the CRO apart.
Delays in a clinical trial process can have serious downstream consequences, such as missing a go-to-market window or preventing life-changing solutions from reaching the people who need them as soon as possible. Here are five tips to reduce the risk of database delays.
Medrio is dedicated to making the clinical trial journey easier by creating thoughtful UX designs that emphasize what’s most important and lead to better participant outcomes. Discover how Medrio provides users with streamlined technology solutions for their clinical trials, as well as tips on improving the participant experience.
Adopting ePRO in early-phase trials can revolutionize data collection, reduce participant burden and increase the accuracy of results. Not only does this improve patient care, but it also provides commercial advantages to sponsors.
Medical device organizations aim to reduce development time by 25% in the next five years. The adoption of ePRO can help make this goal a reality.
Global medical device maker Nevro successfully integrates Medrio EDC and ePRO to transition from paper to digital data collection.
The use of multimedia, including videos, animations, or interactive graphics in clinical trials is growing. Although its impact on the success of clinical trials is not yet fully understood, studies have shown that it can improve participant engagement, comprehension, and retention of study information.
Healthcare reimbursement is starting to use patient-reported outcomes as proof that a drug or treatment improves the quality of life enough to warrant the cost.
CROs face growing pressure to differentiate themselves. Myths about sponsor expectations and priorities surrounding eClinical technology can cause CROs to lose bids.
Sign up to have our the latest insights delivered to your inbox.
